16 October 2020
New Future Leaders Fellow Dr Beccano-Kelly will lead research into synaptic health over time in neurodegeneration. Watch our video interview with Dayne to find out more about his career to date, successful application and future plans.
2 October 2020
A new collaborative study from the Oxford Parkinson’s Disease Centre led by Prof Stephanie Cragg and Dr Bradley Roberts has revealed that GABA transporters on astrocytes, the brain's lesser known yet critically important cells, support dopamine release and are sites of early dysfunction in parkinsonism.
28 September 2020
A collaborative study led by the OPDC's Dr Nora Bengoa-Vergniory has shown that compounds known as molecular tweezers could become a promising disease modifying therapy for Parkinson’s.
25 August 2020
New results from a collaborative Oxford Parkinson’s Disease Centre and Cardiff University study on the cellular origins of Parkinson's could be key to developing new treatments.
14 August 2020
OPDC Career Development Fellow Natalie Connor-Robson was first generation in her family to go to university and is now delighted to be sharing STEM career advice with students taking part in the In2scienceUK programme.
30 July 2020
Researchers from the Oxford Parkinson’s Disease Centre (OPDC) have been paying tribute to Bobbie Coelho, one of the OPDC’s long term fundraisers who has decided to take a step back from active fundraising activities.
30 April 2020
Wade-Martins Lab members took part in the 2.6 challenge to raise vital funds for Parkinson's UK. Challenges included running for 2.6 miles, baking 26 cookies, 260 sit ups and 2600 steps.
24 April 2020
Milena Cioroch, Research Assistant in the Wade-Martins Lab at the Oxford Parkinson's Disease Centre, is undertaking a Management training course as part of the University of Oxford Apprenticeships scheme. She has been awarded Apprentice of the Month for March 2020 by her training provider Abingdon and Witney College. Here we take a closer look at her work for the department and how she has developed her career through the scheme.
4 November 2019
Our Researchers at the Oxford Parkinson’s Disease Centre have shown that cell recycling in Parkinson’s may play a more complex role than previously thought.
1 November 2019
Continuing their series celebrating ‘amazing people at Oxford who you should know about’, Central University's Science Blog talks to Dayne Beccano-Kelly, an electrophysiologist and Career Development Fellow in our department and part of the Oxford Parkinson’s Disease Centre.
29 October 2019
Stewart Humble came to the Wade-Martins Lab at DPAG from Louisiana State University Health Sciences Center in New Orleans during Michaelmas Term in October 2016 as part of the National Institutes of Health Oxford-Cambridge Scholars Programme (NIH-OxCam), an accelerated, individualised doctoral training programme, to help him make the transition to a Physician-Scientist career path. This opened up the world of basic science, translational research, and international collaboration. Over the summer of 2019, Stewart organised a lab symposium to encourage and inspire students from his home university to consider the opportunities available to them. This is the story of his journey to Oxford and what he has discovered here.
28 October 2019
October is Black History Month, which is celebrated nationwide every year to recognise the contributions that people from BAME backgrounds have made to this country. Here at DPAG, we get to know one of our Researchers - Pavandeep Rai, a Postdoctoral Research Scientist working in the Wade-Martins Group. Pavandeep is working at the forefront of an industry/academia collaborative project aimed at developing potential new drugs to treat Parkinson’s.
2 August 2019
Dr Nora Bengoa-Verginory and Bryan Ng from the Wade-Martins Group were invited to deliver talks showcasing their research at the annual event from the Alzheimer’s Research UK Oxford network.
6 June 2019
The talks given by Postdoctoral Research Scientists and Graduate Students highlighted the full range of research in DPAG, spanning molecular and cellular neuroscience all the way to systems neuroscience.
2 May 2019
The Wade-Martins Group has identified how the dysfunction of a key protein, LRRK2, causes the neurons affected in Parkinson's to lose their ability to effectively clear out cell components that have been damaged. This discovery has enabled the team to find a new way to target and correct this issue, paving the way for a potential new clinical treatment.
11 April 2019
A new study from OPDC Career Development Fellow Natalie Connor-Robson investigates how mutations in the gene LRRK2, which are known to cause Parkinson’s, affect normal cell function.